Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward

por Shinada, Kanako, Murakami, Shuji
Publicado 2023

Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

por Ushio, Ryota, Murakami, Shuji, Saito, Haruhiro
Publicado 2022

Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M‐positive: Case report and literature review

por Maeda, Chihiro, Shinada, Kanako, Murakami, Shuji, Saito, Haruhiro
Publicado 2023

Radiation recall pneumonitis after COVID‐19 vaccination

por Shinada, Kanako, Murakami, Shuji, Yoshida, Daisaku, Saito, Haruhiro
Publicado 2021

Case report: anaplastic lymphoma kinase (ALK) rearranged adenocarcinoma with high level of microsatellite instability response to pembrolizumab

por Shigeta, Naoko, Murakami, Shuji, Yokose, Tomoyuki, Miyagi, Yohei, Saito, Haruhiro
Publicado 2023

Readministration of Pembrolizumab after Treatment of Tuberculosis Activated by Initial Pembrolizumab Therapy

por Murakami, Shuji, Usui, Ryou, Nakahara, Yoshiro, Kondo, Tetsuro, Kato, Terufumi, Saito, Haruhiro
Publicado 2020

Tumor invasion in the central airway is a risk factor for early‐onset checkpoint inhibitor pneumonitis in patients with non‐small cell lung cancer

por Moda, Mitsuhiro, Saito, Haruhiro, Kato, Terufumi, Usui, Ryo, Kondo, Tetsuro, Nakahara, Yoshiro, Murakami, Shuji, Yamamoto, Kouji, Yamada, Kouzo
Publicado 2020

Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation Sequencing

por Murakami, Shuji, Yokose, Tomoyuki, Nemoto, Daiji, Suzuki, Masaki, Usui, Ryou, Nakahara, Yoshiro, Kondo, Tetsuro, Kato, Terufumi, Saito, Haruhiro
Publicado 2021

Efficacy of subsequent docetaxel +/− ramucirumab and S‐1 after nivolumab for patients with advanced non‐small cell lung cancer

por Tamura, Nobumasa, Horinouchi, Hidehito, Sekine, Katsutoshi, Matsumoto, Yuji, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2019

Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next‐generation sequencing technique

por Manabe, Saki, Kasajima, Rika, Murakami, Shuji, Miyagi, Yohei, Yokose, Tomoyuki, Kondo, Tetsuro, Saito, Haruhiro, Ito, Hiroyuki, Kaneko, Takeshi, Yamada, Kouzo
Publicado 2020

Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody

por Murakami, Shuji, Shibaki, Ryota, Matsumoto, Yuji, Yoshida, Tatsuya, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2020

Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations

por Murakami, Shuji, Yokose, Tomoyuki, Shinada, Kanako, Isaka, Testuya, Katakura, Kengo, Ushio, Ryouta, Kondo, Tetsuro, Kato, Terufumi, Ito, Hiroyuki, Saito, Haruhiro
Publicado 2022

Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients

por Higashiyama, Ryoko Inaba, Horinouchi, Hidehito, Kuchiba, Aya, Matsumoto, Yuji, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2022

Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease

por Kirino, Yohei, Takeno, Mitsuhiro, Watanabe, Reikou, Murakami, Shuji, Kobayashi, Masayoshi, Ideguchi, Haruko, Ihata, Atsushi, Ohno, Shigeru, Ueda, Atsuhisa, Mizuki, Nobuhisa, Ishigatsubo, Yoshiaki
Publicado 2008

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

por Shibaki, Ryota, Murakami, Shuji, Shinno, Yuki, Matsumoto, Yuji, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Motoi, Noriko, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2019

Mixed response to osimertinib and the beneficial effects of additional local therapy

por Shinno, Yuki, Goto, Yasushi, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2019

Number of metastatic organs negatively affects the treatment sequence in patients with EGFR‐TKI failure

por Mizuno, Takaaki, Horinouchi, Hidehito, Watanabe, Sho, Sato, Jun, Morita, Ryo, Murakami, Shuji, Goto, Yasushi, Kanda, Shintaro, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2020

Evaluation of time to failure of strategy as an alternative surrogate endpoint in patients with lung cancer with EGFR mutations

por Shinno, Yuki, Goto, Yasushi, Watanabe, Sho, Sato, Jun, Morita, Ryo, Matsumoto, Yuji, Murakami, Shuji, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Publicado 2018

Tissue surface area and tumor cell count affect the success rate of the Oncomine Dx Target Test in the analysis of biopsy tissue samples

por Nemoto, Daiji, Yokose, Tomoyuki, Katayama, Kayoko, Murakami, Shuji, Kato, Terufumi, Saito, Haruhiro, Suzuki, Masaki, Eriguchi, Daisuke, Samejima, Joji, Nagashima, Takuya, Ito, Hiroyuki, Yamada, Kouzo, Nakayama, Haruhiko, Masuda, Munetaka
Publicado 2020

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer

por Nishii, Teppei, Yokose, Tomoyuki, Miyagi, Yohei, Daigo, Yataro, Ito, Hiroyuki, Isaka, Tetsuya, Imai, Kentaro, Murakami, Shuji, Kondo, Tetsuro, Saito, Haruhiro, Oshita, Fumihiro, Yamada, Kouzo, Matsukuma, Shoichi, Tsuboi, Masahiro, Nakayama, Haruhiko, Masuda, Munetaka
Publicado 2014